Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.

导出 OA

翻译打印收藏纠错

第一作者： Yongjun,Quan

第一单位： Department of Urology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.

作者： Yongjun,Quan ^[1] ; Xiaodong,Zhang ^[2] ; Hao,Ping ^[3]

作者单位： Department of Urology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. ^[1] Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. ^[2] Department of Urology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. pinghaotrh@ccmu.edu.cn. ^[3] Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing Tongren Hospital, Beijing, 100730, China. pinghaotrh@ccmu.edu.cn. ^[4]

关键词 N6-methyladenosine (m6A)Prostate cancer Recurrence-free survival The Cancer Genome Atlas (TCGA)geneCluster m6Acluster m6Ascore

DOI 10.1186/s12935-021-02438-1

PMID 35045837

发布时间 2022-01-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交